(0.03%) 5 208.00 points
(0.08%) 39 030 points
(-0.10%) 18 177 points
(0.34%) $78.75
(-1.87%) $2.15
(-0.35%) $2 323.00
(-0.50%) $27.48
(-0.20%) $963.00
(0.10%) $0.929
(0.30%) $10.86
(0.21%) $0.798
(-0.19%) $91.17
Quarter results today
(bmo 2024-05-07)
Expected move: +/- 14.35%
4.35% $ 1.200
@ $0.930
Emitido: 14 feb 2024 @ 09:30
Retorno: 29.03%
Señal anterior: feb 13 - 13:27
Señal anterior:
Retorno: -2.14 %
Live Chart Being Loaded With Signals
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases...
Stats | |
---|---|
Volumen de hoy | 3.22M |
Volumen promedio | 3.17M |
Capitalización de mercado | 201.53M |
EPS | $0 ( 2024-05-02 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.11 |
ATR14 | $0.00800 (0.67%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-11 | Taveras Arthur | Sell | 14 235 | Common Stock |
2024-03-11 | Ragan Paula | Sell | 49 678 | Common Stock |
2024-03-11 | Mostafa Adam S. | Sell | 52 500 | Common Stock |
2024-03-11 | Dibiase Mary | Sell | 15 409 | Common Stock |
2024-02-13 | Arbet-engels Christophe | Buy | 180 816 | Stock Appreciation Right |
INSIDER POWER |
---|
80.18 |
Last 96 transactions |
Buy: 15 169 198 | Sell: 1 336 024 |
Volumen Correlación
X4 Pharmaceuticals Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
ALZN | 0.945 |
FATE | 0.943 |
TCRT | 0.942 |
QTEK | 0.937 |
IMCC | 0.932 |
BVXV | 0.928 |
FNCH | 0.923 |
TTCF | 0.921 |
GRAY | 0.919 |
ARQQ | 0.919 |
10 Correlaciones Más Negativas | |
---|---|
DVCR | -0.955 |
BNIXU | -0.951 |
OPNT | -0.944 |
NTUS | -0.94 |
LMNX | -0.939 |
EWEB | -0.937 |
ISIG | -0.932 |
AVEO | -0.93 |
EDUT | -0.924 |
ITMR | -0.921 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
X4 Pharmaceuticals Inc Correlación - Moneda/Commodity
X4 Pharmaceuticals Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-2.00M (0.00 %) |
EPS: | $-0.570 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-2.00M (0.00 %) |
EPS: | $-0.570 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.99M (0.00 %) |
EPS: | $-1.480 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-3.99 |
Financial Reports:
No articles found.
X4 Pharmaceuticals Inc
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the treatment of CXCR4 disorders and primary immunodeficiencies. It has a license agreement with Abbisko Therapeutics Co., Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company was founded in 2010 and is headquartered in Boston, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico